Indicators

Markets:

News

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

...

5 6 7 8 9 10 11 12 Next >

Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100

September 22, 2024

FTC sues drug middlemen for allegedly inflating insulin prices

September 20, 2024

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

September 18, 2024

Healthy Returns: How competitive can Roche be in the weight loss drug market?

September 17, 2024

How the Research Triangle has helped make North Carolina one of America's fastest-growing economies

September 16, 2024

CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain

September 12, 2024

Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs

September 12, 2024

Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs

September 10, 2024

Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

September 05, 2024

5 things to know before the stock market opens Tuesday

September 03, 2024

Weight loss drugs cut Covid-19 deaths, study finds

September 02, 2024

Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply

August 27, 2024

Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program

August 21, 2024

Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial

August 20, 2024

What's next for the Biden administration's Medicare drug price negotiations

August 15, 2024

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

August 15, 2024

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

August 14, 2024

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

August 13, 2024

Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says

August 02, 2024

Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study

August 01, 2024

Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes

July 31, 2024

Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says

July 30, 2024

Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data

July 29, 2024

Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial

July 25, 2024

Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results

July 25, 2024

Healthy Returns: The first round of Medicare drug price negotiations is nearing an end

July 23, 2024

Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment

July 23, 2024

Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche

July 17, 2024

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

July 16, 2024

Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills

July 11, 2024

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.